Stock Markets March 11, 2026

Tel Aviv Market Edges Up as Banking, Financials and Biomed Drive Gains

TA 35 closes 0.57% higher amid mixed breadth and notable moves in individual TASE names

By Priya Menon
Tel Aviv Market Edges Up as Banking, Financials and Biomed Drive Gains

Israel's benchmark TA 35 finished the session up 0.57% as strength in banking, financial and biomed stocks outweighed a larger number of declines across the exchange. Individual large moves included double-digit gains for Next Vision Stabilized Systems and sizable drops for several industrial and energy-related issuers. Commodities and currency markets also registered notable moves during the session.

Key Points

  • TA 35 rose 0.57% at the close, led by gains in the Banking, Financials and Biomed sectors.
  • Top individual performers included Next Vision Stabilized Systems (NXSN) +8.13%, Mizrahi Tefahot (MZTF) +3.30% and Bank Hapoalim (POLI) +3.28%; largest decliners were Dimri (DIMRI) -5.33%, Delek Group (DLEKG) -3.74% and Fattal 1998 Holdings (FTAL) -3.26%.
  • Commodities and FX saw significant moves: April crude rose to $86.89, Brent to $91.54, April gold futures fell to $5,179.49 per troy ounce; USD/ILS and EUR/ILS both strengthened, and the US Dollar Index Futures climbed to 99.22.

Tel Aviv equities ended higher on Wednesday, with the TA 35 index gaining 0.57% at the close as the Banking, Financials and Biomed sectors provided the main upward momentum.

Among TA 35 constituents, Next Vision Stabilized Systems (NXSN) led the session's winners, advancing 8.13% or 2,670.00 points to finish at 35,510.00. Mizrahi Tefahot (MZTF) added 3.30% or 760.00 points to close at 23,780.00, and Bank Hapoalim (POLI) rose 3.28% or 255.00 points to end the day at 8,025.00.

On the downside, Dimri (DIMRI) registered the steepest decline, slipping 5.33% or 2,600.00 points to close at 46,200.00. Delek Group (DLEKG) fell 3.74% or 4,100.00 points to 105,500.00, and Fattal 1998 Holdings Ltd (FTAL) was down 3.26% or 2,080.00 points to 61,790.00 at the close.

Market breadth was uneven: decliners outnumbered advancers by a margin of 320 to 138, with 91 stocks finishing unchanged on the Tel Aviv Stock Exchange.


Movements in commodity markets were pronounced during the session. Crude oil for April delivery rose 4.12% or 3.44 to $86.89 a barrel, while Brent oil for May delivery climbed 4.26% or 3.74 to $91.54 a barrel. Precious metals moved in the opposite direction, with the April Gold Futures contract falling 1.19% or 62.61 to trade at $5,179.49 a troy ounce.

Foreign-exchange and dollar benchmarks also shifted: USD/ILS increased 0.59% to 3.11, EUR/ILS rose 0.26% to 3.60, and the US Dollar Index Futures was up 0.42% at 99.22.


The session's dynamics reflected concentrated gains in select banking and financial names alongside sizeable losses in certain industrial and energy-related stocks. While the TA 35 closed higher, the larger count of falling issues signals uneven participation beneath the headline move.

Risks

  • Market breadth was weak despite the index gain, with 320 decliners versus 138 advancers and 91 unchanged, indicating uneven participation across sectors - this affects overall market stability.
  • Sharp moves in energy futures were recorded, with crude and Brent both rising more than 4%, which introduces commodity-driven volatility that may influence energy and industrial stocks.
  • Notable single-stock volatility was observed among both winners and losers, exemplified by NXSN's strong rally and DIMRI's steep drop, underscoring idiosyncratic risks for investors in individual TASE names.

More from Stock Markets

Solid Biosciences Shares Slide After Company Releases Interim Duchenne Gene Therapy Data Mar 11, 2026 Aetna Agrees to $117.7 Million Settlement Over Medicare Diagnosis Coding Allegations Mar 11, 2026 JPMorgan Adds BridgeBio to Focus List and Lifts December 2026 Target to $94 Mar 11, 2026 McDonald’s to Roll Out Sub-$3 Menu Items and $4 Breakfast Bundles Across U.S. in April Mar 11, 2026 U.K. Stocks Slip at Close as Mining, Telecoms and Industrials Weigh on Market Mar 11, 2026